Northwestern University will serve as a collaborating site for the proposed Boehringer- Ingleheim R2019-01 grant application. The Site PI and Program Manager will complete the collection of deidentified HRCT images, DNA samples, and clinical data.
|Effective start/end date||9/1/20 → 12/31/21|
- University of Michigan (SUBK00014383 // AGMT Correia 8/12/21)
- Boehringer Ingelheim Pharmaceuticals, Inc. (SUBK00014383 // AGMT Correia 8/12/21)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.